Congrats to the LAVA team for the publication of exciting new data from a bispecific Vγ9Vδ2 T-cell engager directed against CD40 in Cancer Immunology Research.
Congrats to the LAVA team for the publication of exciting new data from a bispecific Vγ9Vδ2 T-cell engager directed against CD40 in Cancer Immunology Research.